Evidence map›Paper›PMID 23449735›Full record

ArticleAmerican journal of respiratory cell and molecular biology2013

Human eosinophils express functional CCR7.

Praveen Akuthota, Shigeharu Ueki, Jessica Estanislau, Peter F Weller

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. A novel myeloid cell in murine spleen defined through gene profiling.Journal of cellular and molecular medicine · 2019
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Praveen AkuthotaDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. pakuthot@bidmc.harvard.edu
Shigeharu Ueki
Jessica Estanislau
Peter F Weller
Beth Israel Deaconess Medical Center · USSleepMed · US

Funding

Human Eosinophils: Mechanisms of FunctioningR37AI020241 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WELLER, PETER F · 2010 to 2019
$4.5M
Airways Eosinophils as Antigen-presenting Cells in AsthmaR01AI051645 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WELLER, PETER F · 2001 to 2011
$3.8M
HUMAN EOSINOPHILS: MECHANISMS OF FUNCTIONINGR01AI020241 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WELLER, PETER F · 1985 to 2009
$3.5M
Tetraspanins in Asthma and Eosinophilic Lung DiseaseF32AI081513 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI AKUTHOTA, PRAVEEN · 2009 to 2010
$119k
NIAID NIH HHS F32 AI081513NIAID NIH HHS F32AI081513NIAID NIH HHS R01 AI051645NIAID NIH HHS R01AI051645NIAID NIH HHS R01/R37AI020241NIAID NIH HHS R37 AI020241
6 · The paper itself

Abstract

Human eosinophils display directed chemotactic activity toward an array of soluble chemokines. Eosinophils have been observed to migrate to draining lymph nodes in experimental models of allergic inflammation, yet it is unknown whether eosinophils express CCR7, a key chemokine receptor in coordinating leukocyte trafficking to lymph nodes. The purpose of this study is to demonstrate expression of CCR7 by human eosinophils and functional responses to CCL19 and CCL21, the known ligands of CCR7. Human eosinophils were purified by negative selection from healthy donors. CCR7 expression of freshly purified, unstimulated eosinophils and of IL-5-primed eosinophils was determined by flow cytometry and Western blot. Chemotaxis to CCL19 and CCL21 was measured in transwell assays. Shape changes to CCL19 and CCL21 were analyzed by flow cytometry and microscopy. Calcium fluxes of fluo-4 AM-loaded eosinophils were recorded by flow cytometry after chemokine stimulation. ERK phosphorylation of CCL19- and CCL21-stimulated eosinophils was measured by Western blot and Luminex assay. Human eosinophils expressed CCR7 as demonstrated by flow cytometry and Western blots. Eosinophils exhibited detectable cell surface expression of CCR7. IL-5-primed eosinophils exhibited chemotaxis toward CCL19 and CCL21 in a dose-dependent fashion. Upon stimulation with CCL19 or CCL21, IL-5-primed eosinophils demonstrated dose-dependent shape changes with polarization of F-actin and exhibited calcium influxes. Finally, primed eosinophils stimulated with CCL19 or CCL21 exhibited increased phosphorylation of ERK in response to both CCR7 ligands. We demonstrate that human eosinophils express CCR7 and have multipotent responses to the known ligands of CCR7.

Indexed as

ActinsAniline CompoundsBlotting, WesternCalciumCell ShapeChemokine CCL19Chemokine CCL21ChemotaxisDose-Response Relationship, DrugEosinophilsExtracellular Signal-Regulated MAP KinasesFlow CytometryHumansInterleukin-5PhosphorylationReceptors, CCR7ActinsAniline CompoundsCalciumCCL19 protein, humanCCL21 protein, humanCCR7 protein, humanChemokine CCL19Chemokine CCL21Extracellular Signal-Regulated MAP KinasesFluo 4IL5 protein, humanInterleukin-5Receptors, CCR7Recombinant ProteinsXanthenes

Identifiers

PMID23449735
PMCPMC3727873
OpenAlexW2167060352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.